未登录

R

Rune Kleppe

university of bergen

H指数:24

被引数:1,506

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The dopamine hypothesis for ADHD: An evaluation of evidence accumulated from human studies and animal models

FRONTIERS IN PSYCHIATRY

IF3.2

2024-11-153

OAAI

The effects of phenylalanine and tyrosine levels on dopamine production in rat PC12 cells. Implications for treatment of phenylketonuria, tyrosinemia type 1 and comorbid neurodevelopmental disorders

NEUROCHEMISTRY INTERNATIONAL

IF4

2023-12-018

OA

Structural mechanism for tyrosine hydroxylase inhibition by dopamine and reactivation by Ser40 phosphorylation

NATURE COMMUNICATIONS

IF15.7

2022-01-1039

OAAI

ADHD symptoms in neurometabolic diseases: Underlying mechanisms and clinical implications

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

IF7.9

2022-01-0127

OAAI

Personalized Medicine to Improve Treatment of Dopa-Responsive Dystonia-A Focus on Tyrosine Hydroxylase Deficiency

JOURNAL OF PERSONALIZED MEDICINE

IF3

2021-11-1215

OAAI

Cysteine Modification by Ebselen Reduces the Stability and Cellular Levels of 14-3-3 Proteins

MOLECULAR PHARMACOLOGY

IF3

2021-08-018

OAAI

GADL1 is a multifunctional decarboxylase with tissue-specific roles in β-alanine and carnosine production

SCIENCE ADVANCES

IF12.5

2020-07-1731

OAAI

Involvement of the 14-3-3 Gene Family in Autism Spectrum Disorder and Schizophrenia: Genetics, Transcriptomics and Functional Analyses

JOURNAL OF CLINICAL MEDICINE

IF2.9

2020-06-1312

OAAI

Phosphorylation at serine 31 targets tyrosine hydroxylase to vesicles for transport along microtubules

JOURNAL OF BIOLOGICAL CHEMISTRY

IF3.9

2017-08-0118

OAAI

In vitro characterization of six STUB1 variants in spinocerebellar ataxia 16 reveals altered structural properties for the encoded CHIP proteins

BIOSCIENCE REPORTS

IF4.7

2017-04-2826

OAAI

CONTRIBUTION OF THE 14-3-3 GENE FAMILY TO AUTISM SPECTRUM DISORDER

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2017-01-011

PREAI

Exome chip analyses in adult attention deficit hyperactivity disorder

TRANSLATIONAL PSYCHIATRY

IF6.2

2016-10-1827

OAAI

Zayats, T.; Jacobsen, K. K.; Kleppe, R.; Jacob, C. P.; Kittel-Schneider, S.; Ribases, M.; Ramos-Quiroga, J. A.; Richarte, V.; Casas, M.; Mota, N. R.; Grevet, E. H.; Klein, M.; Corominas, J.; Bralten, J.; Galesloot, T.; Vasquez, A. A.; Herms, S.; Forstner, A. J.; Larsson, H.; Breen, G.; Asherson, P.; Gross-Lesch, S.; Lesch, K. P.; Cichon, S.; Gabrielsen, M. B.; Holmen, O. L.; Bau, C. H. D.; Buitelaar, J.; Kiemeney, L.; Faraone, S. V.; Cormand, B.; Franke, B.; Reif, A.; Haavik, J.; Johansson, S.

Increased microvascular permeability in mice lacking Epac1 (Rapgef3)

ACTA PHYSIOLOGICA

IF5.6

2016-05-1737

OAAI

Regulation of tyrosine hydroxylase is preserved across different homo- and heterodimeric 14-3-3 proteins

IF2.4

2016-01-2915

OAAI

Mammalian CSAD and GADL1 have distinct biochemical properties and patterns of brain expression

NEUROCHEMISTRY INTERNATIONAL

IF4

2015-11-0128

OA

Cell Death Inducing Microbial Protein Phosphatase Inhibitors-Mechanisms of Action

IF5.4

2015-10-2218

OAAI

Phosphorylation Dependence and Stoichiometry of the Complex Formed by Tyrosine Hydroxylase and 14-3-3γ

MOLECULAR & CELLULAR PROTEOMICS

IF5.5

2014-08-0120

OAAI

Functional Studies of Tyrosine Hydroxylase Missense Variants Reveal Distinct Patterns of Molecular Defects in Dopa-Responsive Dystonia

IF3.7

2014-06-0354

OA

Modelling cellular signal communication mediated by phosphorylation dependent interaction with 14-3-3 proteins

IF3

2013-11-205

OA

Cyclic AMP can promote APL progression and protect myeloid leukemia cells against anthracycline-induced apoptosis

CELL DEATH & DISEASE

IF9.6

2013-02-2827

OAAI